Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Apr 20;19(5):1349–1355. doi: 10.1158/1055-9965.EPI-09-1181

Table 1.

Prostate cancer risk association results for top 3 JAZF1 SNPs in 10,286 patients and 9,135 controls

SNP Location r2 with
rs104865
67		 Risk allele freq. χ2 statistics 1p-value Heterozygous Homozygous
(Risk allele) Controls Cases OR 95% CI OR 95% CI
rs10486567 (G) 27,943,088 -- 0.759 0.788 46.55 7.79 × 10−11 1.19 1.12–1.27 1.37 1.20–1.56
rs10807843 (T) 27,958,915 0.893 0.777 0.805 43.88 2.96 × 10−10 1.2 1.12–1.27 1.35 1.17–1.56
rs38504 (C) 27,982,859 0.463 0.79 0.812 26.54 1.73 × 10−6 1.17 1.10–1.24 1.18 1.02–1.36

Results for top 3 JAZF1 SNPs of 106 tested.

1

p-values are for genotype association test (additive model) adjusted for study and significant principal components (see Supplementary Methods).